v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Consolidated net loss $ (496,140) $ (479,115)
Adjustments to reconcile consolidated net loss to net cash and cash equivalents provided by operating activities:    
Depreciation and amortization expense 107,518 106,513
Stock-based compensation expense 543,698 492,393
Operating lease non-cash expense 60,719 57,488
Accretion on marketable securities, net (34,439) (39,533)
Amortization of debt issuance costs 706 679
Impairment expense, (gain)/loss on investment and other asset sales, and other, net 4,686 443
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 87,688 160,045
Prepaid expenses and other current assets (24,485) (12,955)
Deferred cost of revenue (93,321) (52,615)
Other assets (7,164) (6,666)
Accounts payable 13,433 (8,828)
Accrued expenses and other current liabilities 7,684 (23,516)
Developer exchange liability (25,426) 15,423
Deferred revenue 538,756 197,650
Operating lease liabilities (53,087) (29,329)
Other long-term liabilities 12,350 12,318
Net cash and cash equivalents provided by operating activities 643,176 390,395
Cash flows from investing activities:    
Acquisition of property and equipment (39,975) (86,381)
Payments related to business combination, net of cash acquired 0 (2,000)
Purchases of intangible assets 0 (1,370)
Purchases of investments (2,610,824) (1,866,782)
Maturities of investments 1,809,450 1,589,320
Sales of investments 411,691 233,306
Net cash and cash equivalents used in investing activities (429,658) (133,907)
Cash flows from financing activities:    
Proceeds from issuance of common stock 63,692 37,247
Financing payments related to acquisitions 0 (4,450)
Net cash and cash equivalents provided by financing activities 63,692 32,797
Effect of exchange rate changes on cash and cash equivalents 5,677 (1,345)
Net increase/(decrease) in cash and cash equivalents 282,887 287,940
Cash and cash equivalents    
Beginning of period 711,683 678,466
End of period 994,570 966,406
Supplemental disclosure of noncash investing and financing activities:    
Property and equipment additions in accounts payable, accrued expenses and other current liabilities, and other long-term liabilities $ 36,387 $ 23,470